Skip to content

Clinical trials

Phase 2 Coronary Artery Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 2 Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20073
20082
20092
20143
20151
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Montreal Heart Institute2
University Health Network, Toronto2
ActivBiotics1
Andre Denault1
AstraZeneca1
Beijing Inno Medicine Co., Ltd.1
Dr. Amer Johri1
Icahn School of Medicine at Mount Sinai1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Momenta Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease17
Atherosclerosis3
Inflammation2
Myocardial Infarction2
Acute Coronary Syndrome1
Angina, Stable1
Angina, Unstable1
Cardiovascular Diseases1
Cerebrovascular Disorders1
Coronary Disease1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.